J. Michael Woolley

The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research

Ron D. Hays, J. Michael Woolley · PharmacoEconomics · 2000 · 491 citations

Pharmacy, Health Sciences, Health Assessment +14

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

Gerald G. Krueger, Richard G. Langley, A.Y. Finlay et al. · British Journal of Dermatology · 2005 · 135 citations

Medicine, Dermatology, Pharmacotherapy +9

Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction

Philip J. Mease, J. Michael Woolley, Bojena Bitman et al. · The Journal of Rheumatology · 2011 · 125 citations · Full text

Pharmacy, Chronic Disease Control, Functional Assessment +16

Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy

John C. Davis, Désirée van der Heijde, Maxime Dougados et al. · Arthritis & Rheumatism · 2005 · 111 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17

The prevalence of hyperkalemia in the United States

Keith A. Betts, J. Michael Woolley, Fan Mu et al. · Current Medical Research and Opinion · 2018 · 91 citations

Medicine, Nephrology, Hemodialysis +11